News
-
-
-
PRESS RELEASE
Original-Research: Energiekontor AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH has updated its recommendation on Energiekontor AG, reiterating a Buy rating with a target price of EUR 105.00. The company's strong performance in H1 is highlighted, with an expected EBT guidance of €70m - €90m for 2025 -
PRESS RELEASE
New to The Street's Esteemed Client Synergy CHC Corp. (NASDAQ: SNYR) Announces Nationwide EG America Rollout for FOCUSfactor(R) Focus + Energy EG America, 6th Largest U.S. Convenience Chain, Expands Distribution Across 1,600+ High-Traffic Locations
Synergy CHC Corp. announced a significant nationwide retail expansion for FOCUSfactor Focus + Energy beverage line through EG America convenience stores, tapping into booming functional beverage market -
PRESS RELEASE
SonicStrategy Expands Exposure to 38.8 Million S Tokens Across Staking, Delegation, and DeFi Holdings, Reinforcing Institutional Alignment and Long-Term Yield Strategy
SonicStrategy Inc., subsidiary of Spetz Inc., achieves 158% increase in network exposure, reaching 38.8 million S tokens. Validator secures Sonic blockchain, engages in DeFi strategies -
PRESS RELEASE
A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials
NanoViricides, Inc. reports NV-387 antiviral drug could reduce metastatic cancer resurgence caused by viral infections. NV-387 completed Phase I trial, advancing to Phase II -
-
-
-
